Sei Investments Co. Acquires 4,874 Shares of iRadimed Corporation (NASDAQ:IRMD)

Sei Investments Co. boosted its holdings in shares of iRadimed Corporation (NASDAQ:IRMD) by 38.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,624 shares of the medical equipment provider’s stock after buying an additional 4,874 shares during the quarter. Sei Investments Co. owned approximately 0.14% of iRadimed worth $925,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of IRMD. Raymond James Financial Inc. purchased a new position in iRadimed during the fourth quarter valued at approximately $2,319,000. Geode Capital Management LLC increased its holdings in iRadimed by 17.9% during the fourth quarter. Geode Capital Management LLC now owns 222,772 shares of the medical equipment provider’s stock valued at $12,255,000 after buying an additional 33,879 shares during the period. Uniplan Investment Counsel Inc. purchased a new position in iRadimed during the fourth quarter valued at approximately $1,790,000. Nuveen LLC purchased a new position in iRadimed during the first quarter valued at approximately $1,418,000. Finally, Vanguard Group Inc. increased its holdings in iRadimed by 3.3% during the first quarter. Vanguard Group Inc. now owns 554,451 shares of the medical equipment provider’s stock valued at $29,098,000 after buying an additional 17,640 shares during the period. 92.34% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of iRadimed from a “buy” rating to a “strong-buy” rating in a report on Tuesday, May 6th.

Insiders Place Their Bets

In other iRadimed news, Director Monty K. Allen sold 1,102 shares of the firm’s stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $69.10, for a total value of $76,148.20. Following the completion of the sale, the director directly owned 19,898 shares in the company, valued at $1,374,951.80. This trade represents a 5.25% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 36.80% of the stock is currently owned by company insiders.

iRadimed Stock Up 0.3%

Shares of IRMD stock opened at $70.38 on Friday. The firm has a market cap of $895.23 million, a price-to-earnings ratio of 43.44 and a beta of 0.94. iRadimed Corporation has a 52-week low of $43.17 and a 52-week high of $73.47. The company’s 50 day moving average is $61.30 and its 200 day moving average is $56.62.

iRadimed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 28th. Shareholders of record on Monday, August 18th will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.0%. The ex-dividend date is Monday, August 18th. iRadimed’s dividend payout ratio (DPR) is 41.98%.

iRadimed Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.